Iovance Biotherapeutics Inc
Change company Symbol lookup
Select an option...
IOVA Iovance Biotherapeutics Inc
SOFI SoFi Technologies Inc
MBOT Microbot Medical Inc
OLP One Liberty Properties Inc
GNT-A Gamco Natural Resources Gold & Income Trust
AGRI AgriFORCE Growing Systems Ltd
LEN Lennar Corp
PEPL PepperLime Health Acquisition Corp
LOCL Local Bounti Corp
STVN Stevanato Group SpA
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as cancer immunotherapy products designed to harness the power of a patient’s own immune system to eradicate cancer cells. It has developed a new, shorter manufacturing process for tumor infiltrating lymphocyte (TIL) known as Generation 2 (Gen 2), which yields a cryopreserved TIL product. Its lead product candidates include lifileucel for metastatic melanoma and metastatic cervical cancer, as well as LN-145 for metastatic non-small cell lung cancer (NSCLC). In addition, the Company is investigating the combinations of TIL therapy with immune checkpoint inhibitors (ICIs) in metastatic melanoma, cervical cancer (NSCLC), and head and neck squamous cell carcinoma (HNSCC). It is investigating peripheral blood lymphocyte (PBL) therapy for patients with refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

Closing Price
$6.84
Day's Change
0.43 (6.71%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.89
Day's Low
6.28
Volume
(Heavy Day)
Volume:
14,067,030

10-day average volume:
5,760,499
14,067,030
  • Prev Close
    6.41
  • Today's Open
    6.31
  • Day's Range
    6.28-6.89
  • Avg Vol (10-day)
    5.8M
  • Last (time)
    4:00p ET 12/02/22
  • Last (size)
    83
  • 52-Wk Range
    5.42 - 20.60
    LowHigh
  • (12/28/21 - 11/18/22)
    26.20%
  • 108.6%
  • Market Cap
    1.1B
  • Shares Outstanding
    157.8M
  • -2.48
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.4
  • 99.90
  • (% of float 11/15/22)
    12.42

Latest News

November 30, 2022
7:00 am ET
Globe Newswire
November 18, 2022
9:00 am ET
MarketWatch
6:30 am ET
Globe Newswire
November 10, 2022
12:33 pm ET
Globe Newswire
November 07, 2022
8:01 am ET
Globe Newswire
November 04, 2022
12:31 pm ET
Zacks
November 03, 2022
4:01 pm ET
Globe Newswire
October 24, 2022
4:01 pm ET
Globe Newswire
October 10, 2022
7:30 am ET
Globe Newswire
October 05, 2022
8:05 am ET
Globe Newswire
September 12, 2022
7:00 am ET
Globe Newswire
September 06, 2022
4:01 pm ET
Globe Newswire
9:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.